Publications

Publications

281 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis

Zorginstituut Nederland has completed its assessment whether romosozumab (Evenity®) is interchangeable with a product that is ...

Report | 16-12-2020

GVS assessment - extension of further conditions for nintedanib (Ofev®)

Zorginstituut Nederland has completed its assessment of the possible extension of the further conditions for nintedanib (Ofev®) ...

Report | 15-12-2020

Package advice polatuzumab vedotin (Polivy®) in combination with bendamustine and rituximab (Pola-BR) for the treatment of r/r DLBCL

Zorginstituut Nederland has completed its assessment whether polatuzumab vedotin (Polivy®) in combination with bendamustine and ...

Report | 10-12-2020

GVS assessment of tafamidis (Vyndaqel®) for the treatment of wild-type or hereditary transthyretin amyloidosis

Zorginstituut Nederland has completed its assessment whether tafamidis (Vyndaqel®) for the treatment of wild-type or hereditary ...

Report | 03-12-2020

Package advice venetoclax (Venclyxto®) in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)

Zorginstituut Nederland has completed its assessment whether venetoclax (Venclyxto®) in combination with obinutuzumab for the ...

Report | 16-11-2020

GVS assessment of glucagon nasal powder (Baqsimi®) for the treatment of severe hypoglycaemia

Zorginstituut Nederland has completed its assessment whether glucagon nasal powder (Baqsimi®) for the treatment of severe ...

Report | 05-11-2020

GVS assessment of ozanimod (Zeposia®) for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS)

Zorginstituut Nederland has completed its assessment whether ozanimod (Zeposia®) for the treatment of adult patients with ...

Report | 28-10-2020

Package advice esketamine nasal spray (Spravato®) for the treatment of adults with treatment-resistant major depressive disorder

Zorginstituut Nederland has completed its assessment whether esketamine nasal spray (Spravato®) can be included in the insured ...

Report | 30-09-2020

Trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage

Zorginstituut Nederland has completed its assessment whether trastuzumab-emtansine (Kadcyla®) can be included in the insured ...

Report | 24-09-2020

Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients

Zorginstituut Nederland has completed its assessment whether Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) can be ...

Report | 24-09-2020